Literature DB >> 10780690

Use of the anterior interbody fresh-frozen femoral head allograft in circumferential lumbar fusions.

J A Bendo1, J M Spivak, M G Neuwirth, P Chung.   

Abstract

Many studies in the literature have documented the outcome of circumferential lumbar fusions. However, no study has specifically evaluated the performance of the anterior fresh-frozen femoral head allograft as a structural interbody graft material. All office and hospital records, including charts and radiographs, were reviewed to obtain pertinent clinical and radiographic information. The cases included 23 single-level fusions, 22 two-level fusions, and 5 fusions of three or more levels. In all, 88 fusion levels were analyzed radiographically. The mean follow-up time was 28 months (range, 24 to 36 months). All procedures were performed in a single stage. At the latest follow-up, clinical outcome was graded good to excellent in 39 (78%) cases, fair in 8 (16%) cases, and poor in 3 (6%) cases. The average time to anterior radiographic fusion was 6 months (range, 4 to 8 months). The overall fusion rate was 98%. The average preoperative anterior disk space height was 10 mm, 14 mm immediately after operation, and 13 mm at follow-up. The posterior disk space height averaged 5 mm before operation, 7 mm immediately after operation, and 6 mm at follow-up. The average segmental lordosis was 7 degrees before operation, 10 degrees immediately after operation, and 10 degrees at follow-up. Late postoperative disk space collapse of 3 mm or more was noted in 17% of the fused disk spaces examined. Seventy-eight percent of the disk spaces maintained a disk space height greater than that of their preoperative value at the latest follow-up. Segmental lordosis did not change significantly at follow-up. The occurrence of collapse did not correlate with the clinical result, smoking history, or surgical indication (p < 0.05). Perioperative complications included one pleural effusion, two urinary tract infections, and one deep wound infection. Late complications included five painful graft sites and two patients with pseudarthrosis. Fresh-frozen femoral head allograft fulfills its desired function as an anterior structural graft in combination with rigid posterior transpedicular fixation, maintaining the disk space height achieved at surgery while reliably allowing remodeling and incorporation into a solid anterior fusion.

Entities:  

Mesh:

Year:  2000        PMID: 10780690     DOI: 10.1097/00002517-200004000-00009

Source DB:  PubMed          Journal:  J Spinal Disord        ISSN: 0895-0385


  5 in total

1.  Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies.

Authors:  Abhijeet Kadam; Paul W Millhouse; Christopher K Kepler; Kris E Radcliff; Michael G Fehlings; Michael E Janssen; Rick C Sasso; James J Benedict; Alexander R Vaccaro
Journal:  Int J Spine Surg       Date:  2016-09-22

2.  Posterior lumbar interbody fusion using compressive bone graft with allograft and autograft in the pyogenic discitis.

Authors:  Ki Chan An; Joo Yong Kim; Tae Hyoung Kim; Jin Suck Kim; Dae Hyoun Park; Jeon Gyo Kim; Tae Woo Sung
Journal:  Asian Spine J       Date:  2012-03-09

3.  Surgical treatment of pyogenic spondylitis with the use of freeze-dried structural allograft.

Authors:  Seung-Soo Kim; Dong-Ho Kang; Jong-Won Yoon; Hyun Park; Chul-Hee Lee; Soo-Hyun Hwang
Journal:  Korean J Spine       Date:  2014-09-30

4.  Circumferential thoracolumbar corrective fusion with an anterior interbody fresh-frozen femoral head allograft for osteoporotic lower acute kyphosis: a case report.

Authors:  Naohisa Miyakoshi; Eiji Abe; Yoichi Shimada
Journal:  J Med Case Rep       Date:  2009-11-19

5.  Comparing the efficacy of syngeneic iliac and femoral allografts with iliac crest autograft in a rat model of lumbar spinal fusion.

Authors:  Christina Holmes; Benjamin D Elder; Wataru Ishida; Alexander Perdomo-Pantoja; John Locke; Ethan Cottrill; Sheng-Fu L Lo; Timothy F Witham
Journal:  J Orthop Surg Res       Date:  2020-09-15       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.